Paper29620187
Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.
Tang G and 7 others. Int J Oncol, 2018. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation. Papers, record 29620187. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29620187
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histones | Major topic |
| Metformin | Major topic |
| Ovarian Neoplasms | Major topic |
| Polycomb Repressive Complex 2 | Major topic |
| Protein Kinases | Major topic |
| AMP-Activated Protein Kinase Kinases | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Proliferation | |
| Cell Survival | |
| Epigenesis, Genetic | |
| Female | |
| Humans | |
| Methylation | |
| Phosphorylation |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26794276 | Measuring the biological effect of presurgical metformin treatment in endometrial cancer. | Br J Cancer | 2016 | https://conductscience.org/library/papers/26794276 | PubMed |
| 2 | 28620234 | EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion. | Sci Rep | 2017 | https://conductscience.org/library/papers/28620234 | PubMed |
| 3 | 22643892 | Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. | Nat Commun | 2012 | https://conductscience.org/library/papers/22643892 | PubMed |
| 4 | 24460896 | The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis. | Diabetes Obes Metab | 2014 | https://conductscience.org/library/papers/24460896 | PubMed |
| 5 | 20944598 | Epigenetic modifications and human disease. | Nat Biotechnol | 2010 | https://conductscience.org/library/papers/20944598 | PubMed |
| 6 | 23352629 | Association of metformin use with cancer incidence and mortality: a meta-analysis. | Cancer Epidemiol | 2013 | https://conductscience.org/library/papers/23352629 | PubMed |
| 7 | 15196462 | The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. | Curr Opin Genet Dev | 2004 | https://conductscience.org/library/papers/15196462 | PubMed |
| 8 | 22266734 | Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. | Diabetes Care | 2012 | https://conductscience.org/library/papers/22266734 | PubMed |
| 9 | 25663310 | Autophagy and protein kinase RNA-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2 alpha kinase (eIF2α) pathway protect ovarian cancer cells from metformin-induced apoptosis. | Mol Carcinog | 2016 | https://conductscience.org/library/papers/25663310 | PubMed |
| 10 | 22337149 | The insulin and insulin-like growth factor receptor family in neoplasia: an update. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22337149 | PubMed |
| 11 | 11846609 | Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. | Methods | 2001 | https://conductscience.org/library/papers/11846609 | PubMed |
| 12 | 27681864 | Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis. | Ann Oncol | 2016 | https://conductscience.org/library/papers/27681864 | PubMed |
| 13 | 25368099 | Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes. | Diabetes | 2015 | https://conductscience.org/library/papers/25368099 | PubMed |
| 14 | 24985407 | Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. | Cancer Prev Res (Phila) | 2014 | https://conductscience.org/library/papers/24985407 | PubMed |
| 15 | 28289190 | AMPK blocks starvation-inducible transgenerational defects in Caenorhabditis elegans. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28289190 | PubMed |
| 16 | 26277279 | Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity. | Pharmacol Res | 2015 | https://conductscience.org/library/papers/26277279 | PubMed |
| 17 | 22809961 | Metformin is synthetically lethal with glucose withdrawal in cancer cells. | Cell Cycle | 2012 | https://conductscience.org/library/papers/22809961 | PubMed |
| 18 | 27517917 | The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27517917 | PubMed |
| 19 | 24607285 | "Platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit? | Gynecol Oncol | 2014 | https://conductscience.org/library/papers/24607285 | PubMed |
| 20 | 22964433 | SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK. | Mol Cancer Res | 2012 | https://conductscience.org/library/papers/22964433 | PubMed |
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42649936 | Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649936 | PubMed |
| 42193942 | Combined Effect of Metformin and miR-145/miR-23b Co-Transfection on Proliferation and Progression in 2D and 3D Epithelial Ovarian Cancer Models. | Cells | 2026 | https://conductscience.org/library/papers/42193942 | PubMed |
| 41897350 | Metformin-A Type 2 Diabetes Mellitus Drug-And Ovarian Cancer: Anticancer Mechanisms and Therapeutic Implications. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897350 | PubMed |
| 41041224 | The role of epigenetics in cancer: From pathways to the clinic. | J Family Med Prim Care | 2025 | https://conductscience.org/library/papers/41041224 | PubMed |
| 40190675 | Maternal Metformin Administration During the Pre-Gestation Period Improves Transient Cerebral Ischemia Injury in Male Offspring Rats. | Adv Pharm Bull | 2024 | https://conductscience.org/library/papers/40190675 | PubMed |
| 40005128 | The Anti-Aging Mechanism of Metformin: From Molecular Insights to Clinical Applications. | Molecules | 2025 | https://conductscience.org/library/papers/40005128 | PubMed |
| 39595655 | Anti-Diabetic Therapies and Cancer: From Bench to Bedside. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595655 | PubMed |
| 39562830 | Dietary phytosterols induce infertility in female mice via epigenomic modulations. | Commun Biol | 2024 | https://conductscience.org/library/papers/39562830 | PubMed |
| 39115639 | Assessing the antitumor effects of metformin on ovarian clear cell carcinoma. | Hum Cell | 2024 | https://conductscience.org/library/papers/39115639 | PubMed |
| 38981246 | Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway. | Transl Oncol | 2024 | https://conductscience.org/library/papers/38981246 | PubMed |
| 38962452 | Bridging the gap: exploring the causal relationship between metformin and tumors. | Front Genet | 2024 | https://conductscience.org/library/papers/38962452 | PubMed |
| 38929443 | Impacts of Dietary Standardized Ileal Digestible Lysine to Net Energy Ratio on Lipid Metabolism in Finishing Pigs Fed High-Wheat Diets. | Animals (Basel) | 2024 | https://conductscience.org/library/papers/38929443 | PubMed |
| 38627767 | Exosomes biogenesis was increased in metformin-treated human ovary cancer cells; possibly to mediate resistance. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38627767 | PubMed |
| 38584203 | Chromatin modifiers in human disease: from functional roles to regulatory mechanisms. | Mol Biomed | 2024 | https://conductscience.org/library/papers/38584203 | PubMed |
| 38461424 | Investigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38461424 | PubMed |
| 37698682 | Current status and frontier tracking of clinical trials on Metformin for cancer treatment. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37698682 | PubMed |
| 37432627 | The Epigenetic Landscape of Meningiomas. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/37432627 | PubMed |
| 36959680 | Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells. | Clin Epigenetics | 2023 | https://conductscience.org/library/papers/36959680 | PubMed |
| 36875093 | The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. | Front Immunol | 2023 | https://conductscience.org/library/papers/36875093 | PubMed |
| 36545268 | Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2022 | https://conductscience.org/library/papers/36545268 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29620187
GET https://conductscience.org/api/papers/v1/29620187/references?page=2